IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ally Bridge Group (NY) LLC

Q2 2024 Holdings

Filed 2024-08-14 | 25 holdings | $167.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Soleno Therapeutics Inc(SLNO)COM834203309$11.7M286,1627.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$11.6M73,5006.9%
Geron Corp(GERN)COM374163103$11.6M2,736,6636.9%
Merus N VCOMN5749R100$10.3M174,8446.2%
Insmed Inc(INSM)COM PAR $.01457669307$8.6M129,0005.1%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$8.6M195,0005.1%
Alumis Inc(ALMS)COM022307102$8.2M618,7504.9%
Blueprint Medicines Corp(2L9)COM09627Y109$8.2M75,6384.9%
Disc Medicine Inc(IRON)COM254604101$7.5M166,5004.5%
DAY One Biopharmaceuticals I(DAWN)COM23954D109$7.4M536,0954.4%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$7.0M965,4264.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$6.6M169,3693.9%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$6.3M153,3793.8%
Kura Oncology Inc(KURA)COM50127T109$6.3M306,7623.8%
Avadel Pharmaceuticals PLCCOM SHSG29687103$6.0M430,2453.6%
Longboard Pharmaceuticals inCOM54300N103$5.9M218,9813.5%
CG Oncology Inc(CGON)COM156944100$5.5M174,8763.3%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$5.0M218,6143.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$4.4M1,474,9262.6%
Tyra Biosciences Inc(TYRA)COM90240B106$4.2M264,6602.5%
Perspective Therapeutics Inc(CATX)COM NEW46489V302$4.0M396,2422.4%
Black Diamond Therapeutics I(BDTX)COM09203E105$3.9M835,0002.3%
Context Therapeutics Inc(CNTX)COM21077P108$3.8M1,886,2322.3%
Eliem Therapeutics Inc(CLYM)COM28658R106$3.6M500,0002.1%
Promis Neurosciences Inc(PMNEUR)COM NEW74346M406$1.6M1,059,5820.9%